Euroopa Liit - eesti - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - kartsinoom, squamous cell - antineoplastilised ained - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - montelukast - närimistablett - 5mg 49tk; 5mg 20tk; 5mg 28tk; 5mg 200tk; 5mg 15tk; 5mg 50tk; 5mg 14tk; 5mg 90tk; 5mg 56tk

Eesti - eesti - Ravimiamet

pfizer enterprises sarl - karboplatiin - infusioonilahuse kontsentraat - 10mg 1ml 15ml 1tk; 10mg 1ml 5ml 1tk; 10mg 1ml 45ml 1tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - montelukast - närimistablett - 4mg 140tk; 4mg 100tk; 4mg 56tk; 4mg 28tk; 4mg 200tk; 4mg 14tk; 4mg 10tk; 4mg 30tk; 4mg 98tk; 4mg 49tk; 4mg 60tk

Eesti - eesti - Ravimiamet

medac gesellschaft für klinische spezialpräparate mbh - oksaliplatiin - infusioonilahuse pulber - 5mg 1ml 100mg 1tk; 5mg 1ml 150mg 1tk

Eesti - eesti - Ravimiamet

portfarma ehf - montelukast - närimistablett - 5mg 20tk; 5mg 10tk; 5mg 90tk; 5mg 100tk; 5mg 56tk; 5mg 28tk; 5mg 30tk; 5mg 14tk; 5mg 84tk; 5mg 98tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - tsisplatiin - infusioonilahuse kontsentraat - 0,5mg 1ml 100ml 1tk; 0,5mg 1ml 50ml 1tk; 0,5mg 1ml 20ml 1tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - tsisplatiin - infusioonilahuse kontsentraat - 1mg 1ml 100ml 1tk

Eesti - eesti - Ravimiamet

fresenius kabi ab - alanüülglutamiin - infusioonilahuse kontsentraat - 200mg 1ml 100ml 10tk; 200mg 1ml 50ml 10tk; 200mg 1ml 100ml 1tk; 200mg 1ml 50ml 1tk

Eesti - eesti - Ravimiamet

berlin-chemie ag - sulfametoksasool+trimetoprim - tablett - 800mg+160mg 10tk